» Articles » PMID: 16053336

Permeability Dominates in Vivo Intestinal Absorption of P-gp Substrate with High Solubility and High Permeability

Overview
Journal Mol Pharm
Specialty Pharmacology
Date 2005 Aug 2
PMID 16053336
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Three purposes are presented in this study: (1) to study the in vivo regional dependent intestinal absorption of a P-gp substrate with high solubility and high permeability, (2) to study the gene expression difference in the various regions of the intestine, and (3) to study the contributions of P-gp or any other transporters for the absorption of a P-gp substrate. The in vivo permeability of verapamil and propranolol were determined by single-pass in situ intestinal perfusion in rat. The gene expression profiles were measured using Affymetrix GeneChip. Correlation analysis between drug in vivo permeability and expression of 3500 genes was performed with nonparametric bootstrap and ANOVA analysis. The permeability of verapamil and propranolol did not demonstrate regional dependency even though significant differences in gene expression were observed in various regions of the intestine. Verapamil permeability significantly correlates with propranolol permeability in both jejunum and ileum, but did not correlate with the permeability of other hydrophilic compounds (valacyclovir, acyclovir, and phenylalanine). Four different regions (duodenum, jejunum, ileum, and colon) showed distinct gene expression patterns with more than 70-499 genes showing at least 5-fold expression differences. Interestingly, P-gp expression is gradually increased by 6-fold from the duodenum to colon. Despite the distinct gene expression patterns in the various regions of the intestine, verapamil permeability did not correlate with any gene expression from 3500 expressed genes in the intestine. A 2-6-fold P-gp expression difference did not seem to associate verapamil permeability in the various intestinal regions in vivo. These data suggest that P-gp plays a minimal role in the in vivo intestinal absorption process of verapamil with high water solubility and high membrane permeability. The intestinal absorption of verapamil in vivo is primarily dominated by its high permeability. However, it is important to note that the findings in this paper do not undermine the importance of P-gp in oral drug bioavailability, drug disposition from the liver, drug efflux from the blood-brain barrier, and drug-drug interaction.

Citing Articles

Physiologically-Based Pharmacokinetic Modeling of PAXLOVID™ with First-Order Absorption Kinetics.

Sagawa K, Lin J, Jaini R, Di L Pharm Res. 2023; 40(8):1927-1938.

PMID: 37231296 PMC: 10212229. DOI: 10.1007/s11095-023-03538-5.


BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide.

Markovic M, Zur M, Ragatsky I, Cvijic S, Dahan A Pharmaceutics. 2020; 12(12).

PMID: 33276565 PMC: 7761534. DOI: 10.3390/pharmaceutics12121175.


A comparative evaluation of models to predict human intestinal metabolism from nonclinical data.

Yau E, Petersson C, Dolgos H, Peters S Biopharm Drug Dispos. 2017; 38(3):163-186.

PMID: 28152562 PMC: 5412686. DOI: 10.1002/bdd.2068.


Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein.

Ledwitch K, Barnes R, Roberts A Biosci Rep. 2016; 36(2).

PMID: 26823559 PMC: 4793304. DOI: 10.1042/BSR20150317.


Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification.

Incecayir T, Tsume Y, Amidon G Mol Pharm. 2013; 10(3):958-66.

PMID: 23327720 PMC: 3605724. DOI: 10.1021/mp300410n.